Organisation paid for research Program year 2022 Source: CMS Open Payments

Austin Retina Assoc

Neither a doctor nor a teaching hospital

Research payments

$553,863

80 payments

Through program year 2022, Austin Retina Assoc is reported as receiving $553,863 in research payments, across 80 payments.

By program year

1 row

Year	Kind	Amount	Payments
2022	Research	$553,863	80

Breakdown

Who paid Research payments · program year 2022

Genentech, Inc. $553,863 80 payments

Studies the money was for Research payments · program year 2022

A Phase III Study to Evaluate Faricimab in Patients With Branch Retinal Vein Occlusion $200,081 11 payments
A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $80,423 9 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $73,370 13 payments
Faricimab Dme Long Term Extension Rhone X $70,937 14 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $56,237 12 payments
Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $31,656 11 payments
Va2 Phiii $25,170 3 payments
Port Delivery System of Ranibizumab Extension Study $15,990 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.